Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia

por Gilroy, C. A., Capozzi, M. E., Varanko, A. K., Tong, J., D'Alessio, D. A., Campbell, J. E., Chilkoti, A.
Publicado 2020

GIP mediates the incretin effect and glucose tolerance by dual actions on α cells and β cells

por El, K., Gray, S. M., Capozzi, M. E., Knuth, E. R., Jin, E., Svendsen, B., Clifford, A., Brown, J. L., Encisco, S. E., Chazotte, B. M., Sloop, K. W., Nunez, D. J., Merrins, M. J., D’Alessio, D. A., Campbell, J. E.
Publicado 2021